How a Google DeepMind Spinoff Hunts Hidden Drug Targets

# AI Is Getting Better at Finding Where Drugs Can Actually Work Google DeepMind's spinoff company, Isomorphic Labs, has developed new AI software that can identify the precise spots on proteins where drug molecules can attach and do their job—a crucial step that previous AI tools like AlphaFold couldn't handle. This breakthrough could speed up the slow and expensive process of drug discovery, which is why major pharmaceutical companies like Novartis and Eli Lilly have already signed major deals with the startup and invested billions. While AI-designed drugs still face the long hurdle of safety testing before reaching patients, this represents real progress toward making drug development faster and more efficient.